Phase II trial of imaging agent [64Cu]SARTATE enrolls patients with known or suspected NETs Feb. 19, 2021
Rucaparib demonstrates promising activity in BAP1-negative or BRCA1-negative mesothelioma Feb. 19, 2021
Flexion advances FX-201 into high-dose cohort of phase I study in patients with knee osteoarthritis Feb. 19, 2021
RSS